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Abstract
Obesity and diabetes incidence rates are increasing dramatically, reaching pandemic proportions. Therefore, there is an 
urgent need to unravel the mechanisms underlying their pathophysiology. Of particular interest is the close interconnection 
between gut microbiota dysbiosis and obesity and diabetes progression. Hence, microbiota manipulation through diet has 
been postulated as a promising therapeutic target. In this regard, secretion of gut microbiota–derived extracellular vesicles 
is gaining special attention, standing out as key factors that could mediate gut microbiota-host communication. Extracellular 
vesicles (EVs) derived from gut microbiota and probiotic bacteria allow to encapsulate a wide range of bioactive molecules 
(such as/or including proteins and nucleic acids) that could travel short and long distances to modulate important biological 
functions with the overall impact on the host health. EV-derived from specific bacteria induce differential physiological 
responses. For example, a high-fat diet–induced increase of the proteobacterium Pseudomonas panacis–derived EV is closely 
associated with the progression of metabolic dysfunction in mice. In contrast, Akkermansia muciniphila EV are linked 
with the alleviation of high-fat diet–induced obesity and diabetes in mice. Here, we review the newest pieces of evidence 
concerning the potential role of gut microbiota and probiotic-derived EV on obesity and diabetes onset, progression, and 
management, through the modulation of inflammation, metabolism, and gut permeability. In addition, we discuss the role 
of certain dietary patterns on gut microbiota–derived EV profile and the clinical implication that dietary habits could have 
on metabolic diseases progression through the shaping of gut microbiota–derived EV.
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Introduction
Gut microbiota is the set of microbes that colonize the gas-
trointestinal tract of mammals, establishing a mutualistic 
relationship with the host [115]. Gut microbiota is involved 
in a wide range of host essential processes, such as diges-
tion and metabolism (i.e., fat storage, indigestible polysac-
charide degradation, and therapeutic drug metabolization), 
Key points  
1. Gut microbiota-derived extracellular vesicles could be relevant 
players in obesity and diabetes pathophysiology. 
2. Dietary habits could influence metabolic disease outcomes 
by targeting gut microbiota–derived extracellular vesicles 
characteristics and amount. 
3. Nutritional and/or pharmacological approaches based on the 
administration of extracellular vesicles derived from probiotic 
and/or gut microbiota bacteria should be explored as therapeutic 
strategies to treat obesity and diabetes.
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development and physiology of the immune system, gut 
function (i.e., gut permeability regulation and maintenance 
of gut barrier integrity), angiogenesis, pathogen resistance, 
bone homeostasis, or behavior [77, 115]. It should be noted 
that several environmental factors could shape gut micro-
biota composition, including lifestyle issues, antibiotics, or 
diet, the latter being considered an important environmen-
tal factor that could influence gut microbiota composition 
[32, 115]. The alteration of gut microbiota homeostasis, 
commonly known as dysbiosis, has been associated with 
numerous diseases, such as colorectal cancer, inflammatory 
bowel disease, cardiovascular diseases, neurological disor-
ders, autoimmune diseases, obesity, and diabetes [44, 115].
In particular, obesity prevalence is increasing dramati-
cally and it has been estimated that about 57.8% of the world 
adult population will be overweight or obese by 2030 [29, 
66]. Likewise, the global incidence rate of type 2 diabe-
tes, which accounts for 90–95% of all cases of diabetes, is 
also rising: it has been predicted that it will increase from 
6,059 cases per 100,000 in 2017 to 7,079 individuals per 
100,000 in 2030 [39, 67]. The association between weight 
gain and type 2 diabetes risk is well known, by which the 
term “diabesity” has been coined to those cases when type 
2 diabetes is caused by obesity [97, 108]. Obesity and type 
2 diabetes are associated with an increased risk to develop 
a plethora of diseases, such as cardiovascular diseases [22, 
54], mental disorders, [10, 12], or cancer [50], and they have 
also been linked with the severity of infectious diseases, 
such as tuberculosis or COVID-19 [60, 65].
Recent studies have proposed that gut microbiota dysbio-
sis could be involved in the onset and progression of obesity 
and diabetes [32, 112]. Thus, gut microbiota manipulation 
interventions are postulated as new promising approaches to 
treat these metabolic disorders, which include dietary inter-
ventions (such as administration of prebiotics, probiotics, 
symbiotics, or low-fat diets), fecal microbiome transplanta-
tion, or bariatric surgery [1, 32, 37, 94, 112, 129]. Never-
theless, a better understanding of the mechanisms underly-
ing the interaction between gut microbiota and the host is 
mandatory in order to ultimately identify targets through 
which the gut microbiota could be effectively manipulated 
to potentially treat obesity and diabetes.
In recent years, extracellular vesicles (EVs) have emerged 
as crucial players in inter-kingdom communication, includ-
ing those established between gut microbiota and mammals 
[11, 130]. EVs are cell-secreted particles identified in all 
domains of life (eukaryote, bacteria, and even archaea) that 
have the potential ability to regulate cell function in an auto-
crine or paracrine manner [130, 133]. In mammals, depend-
ing on their biogenesis and size, EVs have been classified 
mainly in exosomes, microvesicles, and apoptotic bodies 
[43]. Exosomes are EVs of endocytic origin that range in 
size from 30 to 150 nm [43]. By contrast, microvesicles have 
a diameter ranging from 100 to 1000 nm and are formed 
from plasma membrane; and apoptotic bodies range from 
50 to 5000 nm and are originated from cells undergoing 
apoptosis [43]. Plants can also secrete EVs, whose biogen-
esis, content, and morphology are similar to mammalian 
exosomes, by which they are usually termed as “exosome-
like nanovesicles” [33, 131]. EVs have been also identified 
in both Gram-negative and Gram-positive bacteria [80, 114]. 
Attending to their biogenesis, they have been termed as 
outer-outer-inner and explosive-outer membrane vesicles in 
Gram-negative bacteria, and cytoplasmic membrane vesicles 
in Gram-positive bacteria [122]. As summarized by Cuesta 
et al. [31], bacterial EVs share many similarities with eukar-
yotic EVs, including their size (10–400 nm), morphology 
(spherical particles), and physico-chemical properties (such 
as stability upon freezing and at 37 °C). However, several 
differences have been found regarding characteristics such 
as structure, tolerance to high temperatures, composition, 
and their biogenesis [31]. Of note, a common characteristic 
between eukaryotic and bacterial EVs is the ability to trans-
port genetic material, including microRNAs (miRNAs) or 
miRNA-like molecules, which have been found in a wide 
range of EVs, such as mammalian exosomes, microvesicles 
and apoptotic bodies [103], plant exosome-like nanovesicles 
[132], and bacterial EVs [3].
EV cargo is configured by a wide range of bioactive mol-
ecules, including proteins, lipids, polysaccharides, RNA, 
and DNA [130, 133]. Among the different types of cargo 
encapsulated in EVs, miRNAs have acquired special noto-
riety, since it has been reported that they can modulate gene 
expression in unrelated organisms, including plants-animals, 
plants-bacteria, and animals-bacteria [78]. Remarkably, true 
miRNA-like molecules have been identified in bacteria [78]. 
These molecules are of similar size to eukaryotic miRNAs 
and can be encapsulated and secreted in EVs, which protect 
miRNAs from degradation [78]. In particular, gut micro-
biota-derived EVs have been associated with several host 
functions, including immune system regulation and cancer 
suppression and it has also been suggested that these EVs 
might have a role in gut-brain axis modulation, since it was 
reported that they could reach the central nervous system 
and regulate cerebral function [56, 70, 88]. In addition to 
displaying beneficial effects and their contribution to host 
homeostasis, the alteration of gut microbiota-derived EV 
profile has been associated with the progression of several 
diseases, such as HIV, inflammatory bowel disease, or can-
cer therapy–induced intestinal mucositis [123]. Furthermore, 
gut microbiota–derived EVs, in particular those secreted by 
Paenalcaligenes hominis, could even induce cognitive dis-
orders like Alzheimer’s disease [81].
In this review, we will discuss the potential role of gut 
microbiota and probiotic-derived EVs on obesity, diabetes, 
and inflammation, and we will summarize the current pieces 
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of evidence concerning the influence of diet on gut micro-
biota and probiotic-derived EVs and their potential implica-
tions of this interaction on host health.
Role of gut microbiota and probiotic‑derived 
extracellular vesicles on inflammation, 
obesity, and diabetes
Gut microbiota plays a crucial role in the modulation of host 
physiological processes whose alterations have been strongly 
linked to obesity and diabetes onset and progression (i.e., 
food intake, inflammation, metabolism, and intestinal bar-
rier function) [20, 30, 53, 93]. Growing evidence suggests 
that gut microbiota–derived EVs could be relevant media-
tors in microbe-host cross-kingdom communication, playing 
part in gut microbiota-mediated intestinal homeostasis and 
ultimately being involved in the pathogenesis of metabolic 
diseases.
Effects of gut microbiota and probiotic‑derived 
extracellular vesicles on gut barrier fortification 
and inflammation suppression
Alvarez et  al. [5] evidenced that EVs secreted by the 
probiotic strains of Escherichia coli Nissle 1917 (EcN) 
and ECOR63 could strengthen intact intestinal epithelial 
barrier by upregulating zonula occludens-1 (ZO-1) and 
claudin-14 expression in  vitro and by downregulating 
the leaky protein claudin-2 in human intestinal epithelial 
cell culture monolayers. Another study conducted by the 
same authors [6] showed that EVs isolated from EcN and 
ECOR63 protected the gut epithelial barrier in human 
intestinal epithelial cell culture monolayers infected by 
enteropathogenic E. coli (EPEC). Among the effects 
observed, EcN and ECOR63 EVs prevented tight junction 
protein redistribution and the protein down-regulation 
induced by EPEC, resulting in the neutralization of the 
decrease in intestinal permeability [6]. In this regard, 
Ashrafian et al. [9] evaluated the effect of EVs isolated 
from the commensal bacterium Akkermansia muciniphila 
in the human intestinal epithelial cell culture model Caco-2. 
Remarkably, the authors observed that A. muciniphila EVs 
enhanced tight junction gene expression and down-regulated 
toll-like receptor (TLR) gene expression, which suggested 
a potential role for A. muciniphila EVs in intestinal barrier 
permeability and fortification as well as in inflammation 
reduction [9]. The protective role against inflammatory 
responses mediated by commensal and/or probiotic bacterial 
EVs was ratified by the studies of Hiippala et al. [59], which 
showed that commensal Odoribacter splanchnicus 57 
EVs possessed immunomodulatory properties, mitigating 
the production of the pro-inflammatory cytokine IL-8 in 
enterocyte cultures treated with E. coli-lipopolysaccharide 
(LPS). The anti-inflammatory properties of O. splanchnicus 
could potentially rely on sphingolipids, such as sulfobacin 
B [59]. In addition, Kang et al. [117] also showed that A. 
muciniphila EVs pre-treatment of a colon epithelial cell line 
could hinder the upregulation of pro-inflammatory cytokines 
induced by pathogenic E. coli EVs. The role of gut microbiota 
and probiotic EVs on modulating intestinal inflammation and 
gut barrier integrity has been further confirmed by several 
in vivo studies. For example, Kang et  al. [117] provided 
direct evidence that oral administration of A. muciniphila EVs 
elicited protective effects, attenuating the severity of colitis-
associated phenotype in mice. These effects involved the 
reduction of weight loss and gut barrier disruption and the 
control of inflammatory response [117]. In fact, an independent 
study carried out by Fábrega et  al. [46] also described 
immunomodulatory properties for orally administered 
probiotic EcN EVs, which protected against the development 
of experimental-induced colitis in mice by counteracting weight 
loss, inflammation, and gut barrier damage.
It should be noted that gut microbiota EVs could not only 
exert immunomodulatory functions through their interac-
tion with gut barrier cells, but they could also communicate 
with intestinal immune system cells, thus influencing host 
immunity. In this regard, Bulut et al. [4] determined that 
EVs derived from the commensal bacterium Pediococcus 
pentosaceus triggered immuno-suppressive responses both 
in vitro and in vivo. Using several mouse models of acute 
inflammation, the authors showed that P. pentosaceus EVs 
promoted immune tolerance and inhibited inflammation 
through the direct interaction with bone marrow-derived 
macrophages and bone marrow progenitors by a TLR-
2-dependent mechanism, which stimulates the generation 
of inflammation regulatory cells (M2-like macrophage and 
myeloid-derived suppressor-like cells) [4]. The protective 
effect of gut microbiota EVs against inflammatory disorders 
was also corroborated by Shen et al. [113], who demon-
strated that Bacteroides fragilis EVs prevented colitis devel-
opment in mice by inducing immune tolerance through acti-
vation of dendritic cells [113]. It was also suggested that the 
immunomodulatory effects of B. fragilis were mediated by a 
capsular polysaccharide packaged in EVs [113].
Pro‑inflammatory effects of gut microbiota– 
and probiotic‑derived extracellular vesicles
Although gut microbiota and probiotic-derived EVs have 
shown anti-inflammatory effects, other studies have also 
attributed a pernicious role for some gut microbiota and 
probiotic EVs in triggering pro-inflammatory responses. 
For example, Patten et al. [101] demonstrated that EVs 
derived from the commensal bacterium E. coli C25 could 
promote pro-inflammatory responses in intestinal epithelial 
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cells in vitro by promoting IL-8 secretion. In addition, Cañas 
et al. [17] unveiled that EVs derived from the probiotic EcN 
and the commensal gut microbiota bacterium ECOR12 
could enhance the secretion of pro-inflammatory cytokines 
IL-6 and IL-8 in Caco-2 cells, which suggests a role for the 
EVs of these strains in the modulation of intestinal immune 
responses. Finally, Fábrega et al. [45] reported that EVs 
from EcN and ECOR12 could induce immune and defense 
responses in a human ex vivo model of colonic explants. The 
authors suggested that outer membrane LPS in EVs could 
be an explanatory mechanism for the modulation of immune 
system responses [45]. Among the mechanisms involved, 
EcN and ECOR12-derived EVs upregulated the chemokine 
MIP1α, the pro-inflammatory cytokines TNF-α, IL-6, IL-8, 
and IL-10, and the human beta-defensin-2 (HBD-2), an anti-
microbial host defense peptide involved in intestinal bar-
rier function [48]. They also enhanced IL-22 production, 
which has been involved in intestinal barrier protection and 
its strengthening [45, 86]. It should be highlighted that the 
induction of moderate inflammatory bowel responses is 
critical for gut barrier protection [120]. In fact, it has been 
suggested that gut microbiota–derived EVs with pro-inflam-
matory properties could be mild enough to be beneficial 
and contribute to gut barrier integrity and intestinal homeo-
stasis maintenance through the induction of host immune 
and defense responses [17, 45]. Nevertheless, in a context 
of dysbiosis or host susceptibility to develop inflammatory 
disorders, we speculate that an imbalance in the abundance 
of pro-inflammatory EVs from gut microbiota, a priori to 
be beneficial to the host, may potentially lead to exacer-
bated inflammatory responses eventually harmful to the host. 
In support of this hypothesis, Hickey et al. [58] observed 
that EVs derived from the commensal Bacteroides thetaio-
taomicron could be uptaken by intestinal macrophages and 
elicit inflammatory response by inducing pro-inflammatory 
cytokines (such as TNF-α and IL-1β) production, driving 
colitis development in genetically susceptible mice.
Direct evidence of the effects of gut microbiota 
and probiotic‑derived extracellular vesicles 
on obesity and diabetes pathophysiology
Remarkably, recent reports have confirmed the direct con-
nection between modulation of intestinal immune responses 
and gut barrier integrity to gut microbiota–derived EVs, as 
well as their link to metabolic function, including improve-
ments of metabolic diseases, such as obesity and diabetes. In 
this regard, Chelakkot et al. [23] reported a direct relation-
ship between A. muciniphila EVs and the improvement of 
both gut barrier integrity and metabolic profile in high-fat 
diet (HFD)–induced diabetic mice. Thereby, oral adminis-
tration of A. muciniphila EVs to HFD-fed mice decreased 
gut barrier permeability, reduced body weight gain, and 
improved glucose tolerance [23]. In addition, administration 
of A. muciniphila EVs to LPS-treated Caco-2 cells decreased 
intestinal permeability and improved intestinal barrier integ-
rity through the up-regulation of occludin expression [23]. 
These findings led the authors to propose that A. muciniphila 
EVs could be a therapeutic tool to treat metabolic diseases 
such as obesity and diabetes [23]. This hypothesis was con-
firmed by Ashrafian et al. [8] who demonstrated an effect of 
A. muciniphila EVs on the alleviation of obesity in mice. A. 
muciniphila EVs reduced food intake, body weight, and adi-
posity; increased gut barrier integrity; ameliorated intestinal 
and adipose tissue inflammation; and improved metabolic 
function in HFD-induced obese mice [8]. Indeed, it could 
be suggested that the improvements on host metabolic health 
due to A. muciniphila [35] and other gut microbiota species 
might be mediated, at least partially, through dynamic EV 
production.
In contrast, Choi et al. [25] revealed the implication of gut 
microbiota–derived EVs in the worsening of diet-induced 
metabolic disorders, in the context of gut microbiota dysbio-
sis. After investigating the effect of stool EVs isolated from 
HFD-fed mice, the authors observed that these EVs could 
blunt glucose metabolism by promoting insulin resistance 
in both skeletal muscle and adipose tissue [25]. This study 
demonstrated that Pseudomonas panacis LPS-containing 
EVs were more abundant in HFD-fed mice and they medi-
ated the detrimental effect of the HFD on glucose metabo-
lism [25]. Remarkably, the alteration of gut microbiota EV 
profile was more severe than changes in gut microbe com-
position and, unlike gut microbes, gut microbiota EVs could 
penetrate into the bloodstream and arrive to insulin-sensitive 
tissues [25]. This result suggested that HFD-induced gut 
microbiota dysbiosis could be accompanied by changes in 
gut microbiota EV profile that could have detrimental effects 
on energy homeostasis, and thus contribute to the onset and 
progression of metabolic diseases such as obesity and dia-
betes. Notably, the remarkable role of commensal bacteria-
derived EVs on host physiology and their contribution to the 
pathogenesis of dysbiosis-related diseases have been also 
elucidated by the studies of Yang et al. [134] in the lung 
commensal microbiota. In a mouse model of experimental 
lung fibrosis, the alteration of lung microbiota promoted 
IL-17B production, contributing to the pathogenesis of the 
disease, and such effect was mediated by EVs secreted by 
commensal bacteria of the genera Bacteroides and Prevo-
tella, whose abundance was up-regulated in this pathophysi-
ological context [134].
Some pieces of evidence dealing with the potential effect 
of gut microbiota and probiotic bacteria–derived EVs on 
host physiology (including shaping of energy metabolism, 
immune responses, and gut barrier function) are summarized 
in Table 1.
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Characterization of gut microbiota 
and probiotic‑derived extracellular vesicle cargo
The characterization of gut microbiota and probiotic-derived 
EV cargo has been mainly focused on the analysis of the pro-
teome and occasionally also the lipidome and the genomic 
DNA [4, 14, 16, 23, 25, 45, 59, 75, 98, 113]. Of note, as 
previously described, the effector molecules responsible 
for the effect of probiotic- and gut microbiota-derived EVs 
have been identified [25, 45, 113]. However, the identifica-
tion of bioactive molecules that mediate gut microbiota and 
probiotic-derived EVs is in its infancy, since most of the 
studies have been focused on the characterization of proper-
ties, effects, and cargo of pathogenic bacteria–derived EVs 
rather than commensal bacteria-derived EVs. Furthermore, 
as reviewed by other authors, it should be noted that bacte-
ria-derived EVs are also enriched in numerous molecules 
besides proteins, like glycolipids, lipopolysaccharides, pep-
tidoglycans, and nucleic acids (i.e., DNA and several types 
of RNA, such as rRNAs, tRNAs, mRNAs, and miRNAs-like 
molecules) [36, 130]. For this reason, a more exhaustive 
characterization of the different types of cargo of gut micro-
biota– and probiotic-derived EVs is required, since it cannot 
be ruled out that other bioactive molecules such as miRNAs 
could potentially be responsible for some of the effects of 
these EVs on the host.
However, there are currently limitations to characterize 
gut microbiota-derived EVs, which make the identification 
of the molecules involved in their physiological effects dif-
ficult. Several methods have been carried out to isolate and 
characterize bacterial EVs from in vitro cultures [55, 98]. 
However, the isolation and characterization of the hetero-
geneous profile of the gut microbiota are far more complex. 
As it was pointed out by other authors [95], a major obsta-
cle is the lack of bacterial EV universal markers and their 
size-similarities to mammalian EVs, which complicate their 
separation from mammalian EVs in corporal fluids. Never-
theless, research continues to overcome these limitations, 
and recently Lagos et al. [75] isolated and characterized EVs 
from pig gut microbiota in vitro, and new methods have 
been developed to isolate more effectively bacterial EVs 
from body fluids [124]. Other authors also identified the 
bacterial origin of fecal EVs through the amplification of 
the DNA from the most common gut microbiota phyla by 
PCR [64]. However, exhaustive identification of the origin 
of fluids and fecal-derived EVs and EV-derived molecules, 
such as miRNAs, is still a challenge due to the complexity 
of the material.
Biological effect of miRNA contained within bacterial 
extracellular vesicles
It has been unveiled that bacterial EV-derived miRNAs 
could exert trans-kingdom gene expression regulation and 
influence host biological functions. For example, Choi et al. 
[27] identified miRNA-size small RNAs in periodontal 
pathogen EVs that could downregulate cytokine expres-
sion (IL-5, IL-13, and IL-15) in Jurkat T cells and predicted 
human immune-related target genes, suggesting a potential 
role in shaping host immune system responses. Han et al. 
[57] expanded knowledge on periodontal pathogen EVs 
and revealed that miRNA-like molecules of Aggregatibac-
ter actinomycetemcomitans EVs could enter human mac-
rophages and regulate gene expression, promoting TNF-α 
production. It was also observed that A. actinomycetemcomi-
tans EVs reached the brain in mice and the exogenous RNA 
cargo up-regulated TNF-α expression, which led to propose 
a potential role in neuroinflammatory disorders [57]. Thus, 
it should be explored if, like pathogenic bacteria–derived 
EVs, gut microbiota EVs could carry small RNAs, includ-
ing miRNAs, that may be involved in the crosstalk between 
gut microbiota and the host, as some authors have already 
hypothesized [11, 21, 26, 57].
In fact, the reciprocal interaction, host-gut microbiota 
mediated by host EV-derived miRNAs, has been also docu-
mented. Indeed, the effects of host EV-derived miRNAs on 
gut microbiota-gene expression regulation were described 
by Liu et al. [85]. This pioneering study revealed that gut 
epithelial cells and homeodomain-only protein homeobox 
(HOPX)–positive cells can secrete fecal miRNAs and 
influence gut microbiota gene expression, controlling gut 
microbiota composition and homeostasis [85]. In turn, 
several studies have shown that gut microbiota can affect 
host-miRNA expression and modulate crucial host func-
tions, such as gut permeability, inflammation, or metabo-
lism [34, 96, 125, 127]. A correlation between gut microbi-
ota–induced alterations on host-miRNA profile and obesity 
and type 2 diabetes has been also documented in several 
studies [49, 83, 126]. In addition, probiotic administration 
has also been reported to influence host miRNA expression 
[105]. Thus, indirectly, it has been shown that gut micro-
biota and probiotics could regulate host gene expression 
through their influence on host-miRNA expression. How-
ever, the direct interaction on host gene expression mediated 
by miRNA-like molecules derived from gut microbiota and/
or probiotics EVs must be proven and clarified in future 
experiments.
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Role of diet on the modulation of gut 
microbiota–derived extracellular 
vesicles and the potential consequences 
on metabolic disorder outcomes
Compelling pieces of evidence indicate that diet exerts a 
powerful influence on the composition, abundance, diversity, 
and metabolism of gut microbiota and it could promote gut 
microbiota changes linked to the prevention and/or treatment 
as well as the development and/or progression of metabolic 
disorders [72, 79]. In fact, it has been observed that dietary 
patterns influence gut microbiota populations differentially, 
favoring or inhibiting certain bacterial species [72, 104]. 
Therefore, promotion of a specific gut microbiota composi-
tion profile has been established for a wide range of diets, 
such as vegan/vegetarian diet, gluten-free diet, Western diet, 
or Mediterranean diet, which have an impact on metabolism 
and gut barrier and immune functions [2, 51, 110, 135]. A 
more thorough description of this issue has been summarized 
in other reviews [72, 104]. For instance, the Western diet 
may promote obesity development by switching gut micro-
biota profile towards a decrease of beneficial/protective bac-
teria, reducing gut microbiota diversity, and enhancing local 
(gut) inflammation [2, 7, 41]. By contrast, a vegetarian diet 
has been associated with obesity prevention in several stud-
ies, for example, by increasing the abundance of commensal 
beneficial bacteria (Bacteroides, Prevotella, Clostridium sp.) 
and/or decreasing diversity and inflammation-related bac-
teria (Enterobacteriaceae) [68, 89]. Also, strong adherence 
to the Mediterranean diet has been reported to increase the 
population of some beneficial bacteria, shifting microbiota 
status towards a healthier pattern [107]. Therefore, gut 
microbiota shaping through dietary interventions could be 
an attractive, effective, and non-invasive strategy to prevent 
and/or treat obesity and diabetes.
However, given the growing evidence supporting an 
important role for gut microbiota-derived EVs in gut micro-
biota-host communication, and their influence in physiolog-
ical function whose disturbance has been associated with 
metabolic disorders (i.e., inflammation, gut permeability, or 
metabolism) (see the “Role of gut microbiota and probiotic-
derived extracellular vesicles on inflammation, obesity, and 
diabetes” section), it would be worthy to explore the follow-
ing hypothesis:
1. The impact of diet on gut microbiota–derived EV pro-
file.
2. If the potential modulation of gut microbiota–derived 
EV profile through diet could have an impact on host 
physiology and contribute to the development (or treat-
ment) of metabolic disorders.
Some of these issues are just starting to be explored and 
an intriguing role for diet in shaping gut microbiota-derived 
EV characteristics, such as their production, cargo, and com-
position, is emerging. Remarkably, Tan et al. [118] presented 
evidence supporting the influence of diet on gut microbiota 
EV production. These authors showed that the administra-
tion of a high-protein diet (HPD) enhanced EV production 
in non-dysbiotic mice, activating the gut epithelial TLR4-
signaling pathway [118]. Activation of the TLR4 pathway, in 
turn, increased immune regulators of IgA production (in par-
ticular CCL28) that modulated host-gene expression towards 
an enhancement of IgA production [118]. Notably, the 
authors attributed the gut microbiota–derived EV produc-
tion enhancement to the HPD-induced upregulation of suc-
cinate [118]. Of note, IgA controls bacteria-host interactions 
and is implicated in the maintenance of gut homeostasis by, 
for instance, restricting spatially pathogens and pathogenic 
microbiota, affecting bacterial viability, and modulating 
pathogenicity [84, 99]. Indeed, Luck et al. [87] observed 
that HFD decreased IgA production in mice and attributed 
a functional role for IgA on glucose homeostasis mainte-
nance, gut and adipose tissue inflammation, gut permeabil-
ity, microbiota encroachment, and microbiota composition, 
which suggested an implication for IgA downregulation in 
HFD-induced metabolic diseases. In accordance, Tan et al. 
[118] also determined that HFD did not induce upregula-
tion of succinate production and that gut microbiota-derived 
EVs from HFD-fed mice inhibited immune regulators of IgA 
production, in particular the cytokine APRIL (A Prolifera-
tion-Inducing Ligand), dramatically decreasing IgA levels. 
In this line, some studies have revealed that succinic acid 
or succinate treatments could alleviate obesity in mice [62, 
128] and, as reviewed by other authors, succinate production 
by gut microbiota might have beneficial effects on metabolic 
disorders [47].
Furthermore, Lagos et al. [75] characterized the profile of 
EVs derived from porcine stool samples, determining that 
the secretion of Clostridiales, Bacilli, and Enterobacteri-
ales EVs increased in response to the administration of the 
carbohydrate β-mannan. Indeed, β-mannan administration 
not only stimulated gut microbiota EV production but also 
modified their protein cargo [75]. However, such EVs did 
not carry polysaccharide- or mannan-degrading enzymes, 
so the relationship between β-mannan and EV production 
remains undermined [75]. Deep research regarding the iden-
tification of specific bacterial species whose EV production 
increased after β-mannan treatment, could help to elucidate 
the effect of β-mannan-gut microbiota EV modulation on 
host health.
The impact of diet on the progression of metabolic dis-
orders through shaping gut microbiota–derived EVs char-
acteristic has been partially revealed by Choi et al. [25]. 
These authors reported that administration of a HFD to 
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mice altered the amount, size, and global content of gut 
microbiota EVs [25]. Thus, the characterization of EVs of 
HFD-fed mice stools showed a size decrease of EVs and 
changes in the global protein content profile, marked by an 
increase in LPS, due to the enhancement of EVs derived 
from LPS-expressing Proteobacteria [25]. In this context, 
other studies have observed that LPS (eventually present in 
bacteria-derived EVs) could increase in response to a HFD 
and have identified LPS as a key triggering factor in diabetes 
and obesity onset [19]. LPS might increase metabolic endo-
toxemia, which in turn could disrupt energy homeostasis, 
promote inflammation, induce insulin resistance and diabe-
tes, and enhance body weight gain in mice [19]. Thus, the 
enhancement of LPS-containing gut microbiota EVs could 
potentially be an important underlying mechanism that could 
orchestrate the promotion of metabolic endotoxemia and 
metabolic disorders induced by HFD. In this sense, it has 
been reported that blood levels of LPS-containing EVs are 
higher in patients with intestinal barrier dysfunction; and 
these EVs strongly stimulated secretion of proinflammatory 
cytokines [123]. On the other hand, gut barrier permeability 
may be compromised in patients with obesity and type 2 
diabetes and dietary lipids could aggravate permeability dis-
turbance [52]. Therefore, it would be necessary to confirm 
in humans (1) if gut barrier disruption could enhance the 
translocation of LPS-positive bacterial EVs, (2) if a West-
ern diet could enhance the production of these EVs, and (3) 
further clarify the implication of EVs from LPS-positive 
bacteria in human metabolic disorders, as it was previously 
described in mice.
Interestingly, Müller et al. [92] also showed that probi-
otic-Lactobacilli EV properties could be shaped by their liv-
ing microenvironment. It was found that culture conditions, 
agitation, and pH 5, respectively, modified Lactobacillus 
casei and Lactobacillus plantarum EV protein content and 
strengthened their anti-inflammatory properties, leading to 
the enhancement of IL-10 and TNF-α production after mac-
rophage treatment in vitro [92]. In this context, accumulating 
evidence has demonstrated that EVs derived from bacteria 
commonly used as probiotics possess anti-inflammatory 
properties and could be potentially used to prevent or treat 
inflammatory disorders [28, 38, 71]. For instance, it has been 
described that Lactobacillus paracasei EVs counteracted 
LPS-induced human colorectal cell inflammation in vitro 
and attenuated inflammation responses and ameliorated coli-
tis in mice, suggesting an important role in gut homeostasis 
maintenance [28]. In addition, oral administration of EVs 
derived from A. muciniphila displayed immunomodulatory 
properties and ameliorated HFD-induced obesity in mice 
[8]. On the other hand, several dietary ingredients benefi-
cially affect the growth, survival, and/or activity of probi-
otic bacteria [42, 111]. This finding provides a new avenue 
to analyze if specific food ingredients, in a similar manner 
as culture conditions, could enhance probiotic EV immu-
nomodulatory properties and if these EVs with strengthened 
anti-inflammatory effects could be used to effectively treat 
metabolic diseases, in which inflammation is a hallmark 
[61].
Effect of diet on gut microbiota 
through food‑derived extracellular vesicles
It is worthy of note that a substantial amount of studies have 
shown that dietary EVs can directly interact with mamma-
lian cells, such as tumor cells, epithelial cells, immune sys-
tem cells, or hepatocytes, and they could elicit biological 
functions that could have an impact on host health, even 
emerging as potential therapeutic targets for the treatment 
of a wide range of diseases, such as inflammatory disor-
ders, cancer or steatosis [102, 106]. In addition, dietary EVs 
could be also prominent players in the interaction between 
diet and gut microbiota, which suggests that dietary EVs 
might be implicated in the extensively described effect of 
diet on host physiology. In support of this notion, it has been 
reported that dietary bovine milk exosomes (a particular 
type of EV) could modulate gut microbiota composition, 
which was associated with the increase of short-chain fatty 
acids (SCFAs) levels [121]. In addition, the authors identi-
fied the consequences of exosome-induced gut microbiota 
modulation in mice, suggesting an effect on the maintenance 
of intestinal barrier function and intestinal immune system 
regulation [121]. Notably, results provided by other studies 
have revealed that gut microbiota SCFAs could be useful 
in the improvement of obesity and diabetes [18, 82], but a 
direct connection between the modulation of SCFA produc-
tion by dietary EVs and metabolic counteraction remains 
to be established. However, the direct effect of bovine milk 
exosomes on human health is unclear, since it has been also 
suggested that they could contribute to the pathogenesis of 
obesity and type 2 diabetes [90]. This might be due to the 
fact that several of the most abundant miRNAs of bovine 
milk–derived exosomes could disrupt energy homeostasis, 
influencing processes such as adipogenesis, insulin secre-
tion, or glucose transporters [90]. In addition, it has been 
shown that dietary plant–derived EVs could also shape gut 
microbiota and accumulated evidence suggests that exog-
enous miRNAs (xenomiRs from foods) within EVs could 
influence human health, particularly involving gut micro-
biota and intestinal barrier function [40]. Recently, Teng 
et al. [119] observed that ginger exosome-like nanoparticles, 
through miRNAs, could regulate Lactobacillus rhamnosus 
(LGG) gene expression, influencing the intestinal immune 
system and improving gut barrier integrity, ameliorating 
colitis in mice [119]. It has been reported that LGG admin-
istration has anti-obesity and anti-diabetic properties, being 
able to alter gut microbiota composition, decrease weight 
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gain, inhibit leptin resistance, enhance glucose tolerance and 
insulin sensitivity, and reduce adiposity [24, 63, 69, 100]. 
Thus, manipulation of gut commensal LGG through dietary 
ginger exosome–like nanoparticles containing miRNAs 
may be a promising strategy to treat metabolic syndrome. 
Remarkably, Berger et al. [13] provided direct evidence of 
the functional consequences of plant-derived EVs in obe-
sity and predicted potential EV-encapsulated miRNAs that 
might be involved in the observed effects, but it has not been 
explored whether these EVs could also target gut microbiota 
[13].
Conclusions and future directions
The use of probiotics to treat metabolic disorders in order 
to enhance weight loss and to improve host homeosta-
sis has been an interesting strategy to achieve optimal 
metabolic health reviewed by several authors [76, 109]. 
Alternatively, there is compelling evidence regarding the 
emergence of probiotic- and gut microbiota–derived EVs 
as a potentially safe and effective alternative as compared 
to probiotics, as discussed in recent reviews [91]. In line 
with these findings, in 2013, the European Medicines 
Agency (EMA) approved the bacterial-derived 4CMenB 
vaccine, which is a bacteria extracellular vesicle–based 
vaccine against meningococcal infection for children [15]. 
Indeed, several authors hypothesized that, considering the 
efficacy and safety of this vaccine, likewise, bacterium-
derived EVs could be potentially used as drugs and could 
be administered to modulate host physiology and to treat 
inflammatory diseases [4]. The potential of a new formula-
tion based on probiotic EVs, called probiomimetics, as a 
therapeutic tool to treat inflammatory diseases, has been 
already shown [74]. The probiomimetics are engineered 
therapeutic agents that consist of microvesicles with sur-
face-attached probiotic EVs [74]. Nevertheless, further 
research is needed to clarify whether the observed effects 
of probiotics on improving diet-induced gut microbiota 
dysbiosis [73, 116] could be mediated by their EVs, and 
whether the administration of gut microbiota and probiotic 
EVs could be used as an emerging tool for the prevention 
and management of metabolic diseases, since the avail-
able evidence in this field is limited. In addition, exhaus-
tive characterization of the cargo of probiotic- and gut 
microbiota–derived EVs is still required to identify all the 
bioactive molecules (i.e., miRNAs) responsible for their 
biological effects.
On the other hand, some questions that are poorly 
understood regarding the effects of diet on shaping gut 
microbiota EVs should be elucidated, which include the 
following:
1. To determine to which extent the contribution of diet-
induced microbiota dysbiosis to obesity and diabetes 
pathogenesis is mediated by the alteration of the micro-
biota EV profile.
2. To identify dietary patterns that could potentially lead 
to the establishment of a healthy (i.e., Mediterranean or 
vegetarian diets) or detrimental (i.e., Western or HFD) 
gut EV profile.
3. To favorably modulate the gut microbiota EV profile 
through the administration of certain bacterial EVs, pro-
biomimetics, bioactive compounds, or foods that could 
represent new approaches to tackle metabolic diseases.
Improving the knowledge of the mechanisms underly-
ing the crosstalk between diet, gut microbiota, and the host 
would allow the identification of new therapeutic targets 
for obesity and diabetes prevention and management. As 
presented in Fig. 1, gut microbiota–, probiotic-, and food-
derived EVs could be a key factor of this interaction. Admin-
istration of probiotic- and commensal bacteria-derived EVs 
and/or manipulation of gut microbiota-derived EVs through 
dietary interventions should be explored as potential strate-
gies to prevent and treat metabolic disorders.
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Fig. 1  Schematic model of the hypothetical impact of dietary pat-
terns on gut microbiota extracellular vesicle profile, and the effect of 
probiotic- and gut microbiota–derived extracellular vesicles on meta-
bolic syndrome onset and/or progression. A mechanism by which 
unhealthy dietary patterns could contribute to obesity and/or diabetes 
progression could be the promotion of gut microbiota dysbiosis and 
the enhancement of detrimental gut microbiota-derived extracellular 
vesicles amount. In turn, these extracellular vesicles could poten-
tially impair gut barrier permeability and intestinal inflammation, 
and could be distributed to peripheral organs through systemic circu-
lation, impairing metabolism and promoting inflammation, and sub-
sequently aggravating the severity of metabolic disorders. Enhance-
ment of beneficial gut microbiota extracellular vesicles through plants 
and plant-derived extracellular vesicles from healthy dietary patterns 
and/or the administration of formulations based of probiotic- and 
gut microbiota–derived extracellular vesicles could potentially be a 
strategy to treat metabolic disorders by counteracting dysbiosis, gut 
permeability increase, inflammation, metabolic homeostasis distur-
bances, and nervous-system derangements. Formulations based on 
bacterial extracellular vesicles could be optimized in order to increase 
their properties and effects by designing efficient therapeutic agents 
(i.e., probiomimetics, which are bacterial derived extracellular vesi-
cles coupled to microvesicles), establishing optimal cell culture con-
ditions or administrating certain food-ingredients. All the hypotheses 
presented in this model must be further confirmed; especially the 
ones marked with dashed arrows should be proven. Brain template 
from BioRender (https:// biore nder. com)
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